Optical coherence tomography aids retinal diagnosis, treatment
July 1st 2009Optical coherence tomography (OCT) can be an effective diagnostic tool that enables optometrists to examine the retina layer by layer. It also can offer quantitative data about the retinal nerve fiber layer. Some doctors believe that the biggest advantage of OCT is what it reveals about the vitreomacular interface.
Winning new patients depends on your value proposition
July 1st 2009Increasing market share for your practice includes an honest assessment of the benefits your practice brings to prospective patients. Consider their needs and preferences carefully to help you devise a value proposition that will make your practice their top choice.
Women's eye-health education needed
July 1st 2009Results of a survey conducted by Transitions Optical reveal that women are significantly more likely than men to experience various eye conditions and vision problems and more likely to identify certain health and environmental factors as negatively affecting vision.
Bepotastine besilate ophthalmic solution 1.5% clears the hurdle for allergic ocular itching
July 1st 2009The FDA Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of bepotastine besilate ophthalmic solution 1.5% (Bepreve, ISTA Pharmaceuticals) for treating ocular itching associated with allergic conjunctivitis.
Spectral-domain optical coherence tomography enables clinical assessment of photoreceptor integrity
July 1st 2009New spectral-domain optical coherence tomography technology allows visualization of the junction of the inner and outer segments of the photoreceptors. Assessment of the photoreceptor integrity line in eyes with and without disorders of the outer retina indicates it is a useful biomarker for photoreceptor impairment.
Besifloxacin ophthalmic suspension 0.6% is approved for bacterial conjunctivitis
July 1st 2009Besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch & Lomb) was approved recently by the FDA for the treatment of bacterial conjunctivitis. Besifloxacin suspension is able to fight bacteria that are growing resistant to older anti-infectives.
Maui Jim, Unite for Sight join forces for charity
July 1st 2009Every online purchase of any new pair of Maui Jim sunglasses from www.mauijim.com through July 31 will result in the donation of a pair of new Maui Jim sunglasses to Unite for Sight, a non-profit group that has as its goal improving eye health and eliminating preventable blindness among severely impoverished people.
Dry eye could be aided by tear osmolarity device
July 1st 2009A new device (TearLab Osmolarity System, TearLab Corp.) that measures the osmolarity of tears to aid in the diagnosis of dry eye disease has been given FDA 501(k) clearance and also has received a silver 2009 Medical Design Excellence Award (MDEA).